Pranlukast
-
Pranlukast
structure -
-
CAS No:
103177-37-3
-
Formula:
C27H23N5O4
-
Chemical Name:
Pranlukast
-
Synonyms:
Benzamide,N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-;Benzamide,N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-;N-[4-Oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide;RS 411;ONO 1078;Pranlukast;ONO-RS 411;SB 205312;8-[4-(4-Phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;Onon;CCN 00401;Azlaire;4-Oxo-8-[4-(4-phenylbutoxy)benzoylamino]-2-(tetrazol-5-yl)-4H-1-benzopyran
- Categories:
-
CAS No:
Description
Off-white solidPranlukast, a novel chromone derivative, was introduced in Japan for the treatment of bronchial asthma and allergic diseases. Pranlukast is a highly potent, selective and competitive antagonist of peptidoleukotrienes with high affinity for the LTD4 receptor. The therapeutic potential of pranlukast in managing irritable bowel syndrome has been suggested. Pranlukast is a common respiratory drug, it belongs to asthma drugs.
N-[4-oxo-2-(2H-tetrazol-5-yl)-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide is a member of chromones.|Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.
Pranlukast Basic Attributes
481.5
481.50
201-616-4
TB8Z891092
DTXSID9021180|DTXSID3043782
R - Respiratory system
Characteristics
119
4.2
off-white solid
1.374±0.06 g/cm3(Predicted)
236-238°C
1.681
Store at +4°C
LD50 in male mice (mg/kg): >1000 i.v. (Toda)
Safety Information
11-34
16-26-36/37/39-45
CV5647500
F,C
P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362
H315
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 40 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Toxicity
Side effects include headache, abdominal or stomach pain, cough, dental pain, dizziness, fever, heartburn, skin rash, stuffy nose, weakness or unusual tiredness.
Drug Information
Used as an adjunct to the standard therapy of inhaled steroids with inhaled long- and/or short-acting beta-agonists.
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist.
A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)|Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)
Hepatic
Pranlukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Pranlukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.
8-(4 (4-phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)-4-oxo-4H-1-benzopyran
Pranlukast Use and Manufacturing
Labeled Pranlukast, intended for use as an internal standard for the quantification of Pranlukast by GC- or LC-mass spectrometry.Premastast is a commonly used respiratory medicine, belongs to antiasthmatic drugs, is a cysteine leukotriene (LTs) receptor antagonist, and selectively binds with LTC4, LTD4, LTE4 receptors to antagonize its effect .
Computed Properties
Molecular Weight:481.5
XLogP3:4.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:9
Exact Mass:481.17500423
Monoisotopic Mass:481.17500423
Topological Polar Surface Area:119
Heavy Atom Count:36
Complexity:778
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Unspecified
Registered Holders
-
Cheer Fine Pharmaceutical Co., Ltd.
Active
Japan
-
Beijing Fuweisi Biotechnology Co., Ltd.
Active
China
-
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Active
China
Recommended Suppliers of Pranlukast
-
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of N-Diethyl-m-toluamide,6-Methyluracil,Anisole,4-Dimethoxybenzoic acid,CS (lacrimator),Daucosterol,N,N-Formylmorpholine,Epichlorohydrin,Tetramethylguanidine,Dimethicone,3InquiryCAS No.: 103177-37-3Grade: Industrial Grade -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Herb Extracts,Cosmetic raw materails,APIInquiryCAS No.: 103177-37-3Grade: Pharmaceutical GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVE -
CN
2 YRS
Business licensedTrader Supplier of API,Antibiotics,Anti cancer category
Learn More Other Chemicals
-
Theophylline
58-55-9
-
Metaproterenol sulfate
5874-97-5
-
Benproperine phosphate
19428-14-9
-
9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one Formula
84661-23-4
-
Suplatast tosilate Formula
94055-76-2
-
Seratrodast Formula
112665-43-7
-
Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1) Structure
151767-02-1
-
Zileuton Structure
111406-87-2
-
What is 2-[2-(Dimethylamino)ethoxy]ethyl 10H-phenothiazine-10-carboxylate
477-93-0
-
What is 2-Hydroxy-4-methylbenzenesulfonic acid
22356-80-5